Sharpening a Double-Edged Sword: Bispecific CAR-T Cancer Therapies

Back to Webinars

Featured Speakers: David Miklos, MD, PhD, Chief Clinical Director, Blood and Marrow Transplantation and Cellular Therapy, Cancer Cell Therapy Stanford University

First Name*

Last Name*

Email*

Company Name*

Country*

Application Area*

Research Area*

By submitting this form, I confirm that I would like to receive information from Bruker Cellular Analysis and I agree to the Website Privacy Policy and Terms of Conditions.*

What's Inside

In this Webinar we discuss:

CAR-T benefits are T cell dependent

Treatment schema for CAR-T cell therapy

Explore several case studies

Watch the Webinar

Back to the Top